Skip to content

Design and implementation of health interventions to reduce occupational lead exposure among foundry workers

Design and implementation of health interventions to reduce occupational lead exposure among foundry workers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240414061486N2
Enrollment
21
Registered
2025-07-18
Start date
2025-07-23
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

occupational disease. Occupational exposure to risk factors

Interventions

Intervention group: comprises workers from the factory's smelting and casting sections who are directly exposed to lead-containing processes. A comprehensive intervention package has been designed, wh

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Workers employed in the smelting and casting sections of the factory who are directly exposed to lead-related processes will be eligible to participate in the study. These individuals must have at least one year of work experience in these sections and must provide written consent to participate in the study. Furthermore, workers who are in relatively stable health and do not have severe chronic diseases related to the kidneys, heart, and blood vessels will be included in the study.

Exclusion criteria

Exclusion criteria: Workers who, for any reason, do not wish to continue their participation during the course of the study or who temporarily or permanently leave the factory will be excluded from the study. Additionally, workers who develop new acute or chronic diseases that may affect the study outcomes, or those who are unable to provide blood samples during the follow-up period, will be excluded from the data analysis.

Design outcomes

Primary

MeasureTime frame
Blood lead level. Timepoint: Beginning of the study and 3 months after intervention implementation. Method of measurement: Serum lead level analysis using Atomic Absorption Spectroscopy.;Blood pressure. Timepoint: Beginning of the study and 3 months after intervention implementation. Method of measurement: Mercury sphygmomanometer.;Kidney function. Timepoint: Beginning of the study and 3 months after intervention implementation. Method of measurement: creatinine; blood urea nitrogen.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNegin Kassiri

Iran University of Medical Sciences

kassiri.n@iums.ac.ir+98 21 8670 3170

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026